Arkolith/Insider Trading/ALLO/Form 4

Chang David D

President and CEO, DirectorAllogene Therapeutics, Inc. (ALLO) · full profile →Form 4 · filed Feb 5, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$77K
Net Open-Market Flow
-$77K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 3, 2025Sell(S)46K$1.68$77K5.3M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001737287-25-000017) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML